Logo Image
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsPeer ExchangeInsightsCase StudiesCase of the QuarterClinical ForumsPractice OwnershipRapid ReadoutShortsVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Elad Kedar

Advertisement

Articles by Elad Kedar

FDA approves low-dose pilocarpine hydrochloride 0.4% as a treatment for presbyopia

ByLynda Charters,Emily Kaiser Maharjan, Assistant Managing Editor,Elad Kedar,Paul Smith
October 18th 2023

Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.

Pipeline: Presbyopia treatment to finish Phase 3 late 2021

ByElad Kedar,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor
June 4th 2021

Orasis Pharmaceuticals drop in development for treating presbyopia

Advertisement

Latest Updated Articles

  • Pipeline: Presbyopia treatment to finish Phase 3 late 2021
    Pipeline: Presbyopia treatment to finish Phase 3 late 2021

    June 4th 2021



Advertisement
Advertisement

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

1

"Do not dismiss these children": Dr Lotfi Merabet's message on CVI

2

Monthly pipeline update: August 2026

3

The Independent Advantage S02 E01: Implementing AI into your practice: It's not why, it's how

4

From Paper to Clinic, Episode 7: GLP-1s and idiopathic intracranial hypertension

5

Beyond the tear film: The emerging role of periocular rehabilitation in comprehensive dry eye care

  • Advertise
  • About Us
  • Editorial
  • Contact Us
  • Job Board
  • Terms & Conditions
  • Privacy
  • Do not sell my Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
Collaborative Care Symposium
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us